The inventors
Dr. Peter Wehling, MD, PhD
Peter Wehling, MD, PhD is the Founder of the Regenokine® Program, author of numerous scientific studies and of the book “End of Pain”. He is a German specialist for orthopedics, sports medicine and chronic pain conditions.
Together with his daughter Dr. Jana Wehling, MD, they steadily evolved through pioneering research the Regenokine® Program over the last year.
Dr. Jana Wehling and Dr. Peter Wehling run their own private clinic, Dr. Wehling & Partner, which specializes in chronic pain management and sports medicine in Düsseldorf, Germany.
Over many years, Drs. Wehling’s and colleagues formulated a biological paradigm of placing inflammation, oxidative stress, and tissue repair deficiency at the center of many orthopedic diseases. They consider the process of resolution to be an active process where a multitude of biomolecular pathways play a key role. This belief has driven Drs. Wehling’s research and collaboration with other institutions and clinical application of the Regenokine® Program.
Drs. Wehlings investigated various aspects of what has become the Regenokine® Program with researchers at a number of well-regarded academic institutions, including:
Duke University, USA
McGill University, Canada
Harvard University, USA
University of North Carolina, USA
Heinrich Heine University Düsseldorf, Germany
University Hamburg, Germany